Monoaminergic actions of ECT.
Rudorfer
M V
MV
Section on Clinical Pharmacology, National Institute of Mental Health, Bethesda, MD.
Manji
H K
HK
Potter
W Z
WZ
D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015306:Biogenic Monoamines / Q000097:blood / Q000134:cerebrospinal fluid / Q000502:physiology*; D004565:Electroconvulsive Therapy; D006801:Humans; D019964:Mood Disorders / Q000503:physiopathology / Q000628:therapy*; D051381:Rats
D000928:Antidepressive Agents; D015306:Biogenic Monoamines